Partner in smart MDx assay development

Multiplex qPCR - Point of Care Applications - Antibiotic Resistance Detection

NYtor designs and develops molecular detection assays in the field of human and veterinary infectious disease diagnostics. Our main focus is the development of smart molecular assays for the detection of antibiotic resistance.

Tailor-made applications and approaches. NYtor is a reliable business partner, focusing on long-term relationships based on personal interactions.

Technology:
  • Microbial diagnostics

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental

Development stage:
  • Research
  • Development

Organization:
  • Company

Partnering:
  • Co-develop

Organisation looking for support in development and route to market of molecular diagnostic assays.

NYtor employs an enthusiastic and motivated team of PhDs and technicians with ample experience and state-of-the-art knowledge of MDx assay development

Assays available for commercialization:
STIs:
• NG + quinolone resistance
• MG + macrolide and quinolone resistance

CPE/ESBL:
• CPE : KPC, OXA48 (including OXA181), VIM and NDM (+IMP)
• ESBL : CTX-M-1; CTX-M-2; CTX-M-9 groups and SHV-ESBL


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!